The corneal endothelium is a single cell layer that lines the innermost surface of the posterior cornea and regulates corneal hydration.
1 Corneal endothelial dystrophies, infections, inflammation, or traumatic insults can cause the human corneal endothelial cell (HCEnC) density to fall below a critical threshold of 500 to 1000 cells/mm
2, with subsequent corneal edema and blindness.
2,3 Currently, the only therapy for endothelial dysfunction is allogeneic transplantation, using either a full-thickness corneal graft, that is, penetrating keratoplasty (PK), or a partial-thickness endothelial graft, that is, Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's membrane (DM) endothelial keratoplasty (DMEK).
4–6 However, reported successes of descemetorhexis without endothelial keratoplasty (DWEK) and DM transplantation (DMT) procedures that involve DM removal without endothelial graft transplantation, as well as DM endothelial transfer (DMET) in which a nonadherent endothelial graft is inserted into the anterior chamber, imply that host cells can contribute to native endothelial regeneration.
7–12 Recent identification of potential endothelial progenitor cells, particularly in the peripheral transition zone (TZ), supports the hypothesis that cell migration from the periphery contributes to this spontaneous regeneration.
13,14 For patients with a large diameter endothelium/DM complex, the increased migration distance between the peripheral progenitor cells and central defects could limit the potential regenerative response. However, a larger endothelium/DM complex, containing a greater absolute number of HCEnCs, could decrease the amount of cell spreading needed to cover a central defect and mitigate loss of functional reserve.
15 Due to migration distance and functional reserve, host endothelium/DM size and the amount removed in DMET/DWEK/DMT may influence the regenerative response from these procedures;
12 hence, discrepancies in native host endothelium/DM size might partially explain why DMET/DWEK only achieve satisfactory visual recovery in a subset of patients.
12,16,17 Additionally, cellular therapies, such as intracameral HCEnC injection, are emerging as potential clinical alternatives to corneal transplantation (Ong, et al.
IOVS. 2017;58:ARVO E-Abstract 1476).
18–20 A portion of the host endothelium must be cleared before injection to facilitate attachment of injected cells to the native DM, and determination of the amount of endothelium to be removed will require knowledge of the endothelium/DM size.
12,21 As such, it would be beneficial to identify an accurate in vivo measurement parameter of the host endothelium/DM complex. Furthermore, to this point the TZ has been characterized only in vitro, via scanning electron microscopy (SEM)
22 or immunostaining.
13,23 The ability to measure this region in vivo would enable clinicians to improve our understanding of TZ functionality.